Morphine exposure and prematurity affect flash visual evoked potentials in preterm infants.

Area of Science:

• Neonatal neurology
• Developmental neuroscience
• Visual electrophysiology

Background:

• Preterm infants face risks for neurodevelopmental impairments.
• Flash-visual evoked potentials (VEPs) assess visual pathway maturation.
• Perinatal factors, including medication and prematurity, may influence VEPs.

Purpose of the Study:

• To investigate the impact of perinatal risk factors on flash-VEP characteristics in preterm infants at term equivalent age (TEA).
• To determine if VEP morphology correlates with neurological outcomes at 2 years corrected age (CA).

Main Methods:

• Multivariate and logistic regression analyses were used to assess VEP parameters (N2, P2, N3 latencies, P2 amplitude, N4 presence, VEP morphology).
• Predictors included gestational age (GA), bronchopulmonary dysplasia (BPD), postmenstrual age, and cumulative doses of morphine and fentanyl.
• Linear regression models examined the association between VEP morphology and Bayley-III cognitive/motor scores at 2 years CA.

Main Results:

• Morphine exposure predicted N2, P2, and N3 latencies.
• Younger gestational age (GA) was linked to lower P2 amplitude.
• No independent variables predicted N4 component presence or VEP morphology; VEP morphology did not correlate with 2-year cognitive or motor scores.

Conclusions:

• Morphine treatment and prematurity are significant risk factors for altered VEP parameters in preterm infants.
• VEP morphology in this cohort did not serve as a predictor for neurological outcome at 2 years corrected age.